IT1163772B - Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche - Google Patents

Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche

Info

Publication number
IT1163772B
IT1163772B IT22045/83A IT2204583A IT1163772B IT 1163772 B IT1163772 B IT 1163772B IT 22045/83 A IT22045/83 A IT 22045/83A IT 2204583 A IT2204583 A IT 2204583A IT 1163772 B IT1163772 B IT 1163772B
Authority
IT
Italy
Prior art keywords
effect
oligosaccharides
alpha
hydosanes
mucopolysaccharides
Prior art date
Application number
IT22045/83A
Other languages
English (en)
Other versions
IT8322045A1 (it
IT8322045A0 (it
Inventor
Massimo Baldacci
Ugo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Publication of IT8322045A0 publication Critical patent/IT8322045A0/it
Priority to IT22045/83A priority Critical patent/IT1163772B/it
Priority to DE8484108229T priority patent/DE3483801D1/de
Priority to AU30538/84A priority patent/AU577300B2/en
Priority to AT84108229T priority patent/ATE59656T1/de
Priority to EP84108229A priority patent/EP0134502B1/en
Priority to JP59144524A priority patent/JPS6038390A/ja
Priority to ZA845434A priority patent/ZA845434B/xx
Priority to CA000458868A priority patent/CA1277937C/en
Publication of IT8322045A1 publication Critical patent/IT8322045A1/it
Application granted granted Critical
Publication of IT1163772B publication Critical patent/IT1163772B/it
Priority to US07/554,972 priority patent/US5470965A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT22045/83A 1983-07-13 1983-07-13 Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche IT1163772B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT22045/83A IT1163772B (it) 1983-07-13 1983-07-13 Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
EP84108229A EP0134502B1 (en) 1983-07-13 1984-07-12 Heparan sulfate fractions, process for their preparation and compositions thereof
AU30538/84A AU577300B2 (en) 1983-07-13 1984-07-12 Heterogeneous oligosaccharides
AT84108229T ATE59656T1 (de) 1983-07-13 1984-07-12 Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.
DE8484108229T DE3483801D1 (de) 1983-07-13 1984-07-12 Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.
JP59144524A JPS6038390A (ja) 1983-07-13 1984-07-13 ヘパラン硫酸塩分画、それを得る方法および製薬学的組成物
ZA845434A ZA845434B (en) 1983-07-13 1984-07-13 Complexable heterogeneous oligosaccharides and alpha-hydosanes having therapeutical activity,process for their preparation and related pharmaceutical compositions
CA000458868A CA1277937C (en) 1983-07-13 1984-07-13 Complexable heterogeneous oligosaccharides and alpha-hydosanes having therapeuticaltivity, process for thier preparation and related pharmaceutical compositions
US07/554,972 US5470965A (en) 1983-07-13 1990-07-17 Complexable heterogenous oligosaccharides and alpha-hydosanes having therapeutical activity, process for their preparation and related pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22045/83A IT1163772B (it) 1983-07-13 1983-07-13 Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
IT8322045A0 IT8322045A0 (it) 1983-07-13
IT8322045A1 IT8322045A1 (it) 1985-01-13
IT1163772B true IT1163772B (it) 1987-04-08

Family

ID=11190660

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22045/83A IT1163772B (it) 1983-07-13 1983-07-13 Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche

Country Status (9)

Country Link
US (1) US5470965A (it)
EP (1) EP0134502B1 (it)
JP (1) JPS6038390A (it)
AT (1) ATE59656T1 (it)
AU (1) AU577300B2 (it)
CA (1) CA1277937C (it)
DE (1) DE3483801D1 (it)
IT (1) IT1163772B (it)
ZA (1) ZA845434B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1208509B (it) * 1985-03-13 1989-07-10 Mediolanum Farmaceutici Srl Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
AU7742591A (en) * 1990-04-06 1991-10-30 Washington University Anticoagulant oligosaccharides
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908004A (en) * 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2535324A1 (fr) * 1982-10-27 1984-05-04 Choay Sa Station perfectionnee pour l'epuration d'eaux usees
IT1189298B (it) * 1982-06-18 1988-02-04 Manetti & Roberts Italo Brit Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
FR2538404B1 (it) * 1982-12-28 1985-08-23 Anic Spa
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina

Also Published As

Publication number Publication date
EP0134502B1 (en) 1991-01-02
AU3053884A (en) 1985-01-17
ATE59656T1 (de) 1991-01-15
EP0134502A1 (en) 1985-03-20
CA1277937C (en) 1990-12-18
US5470965A (en) 1995-11-28
ZA845434B (en) 1985-02-27
IT8322045A1 (it) 1985-01-13
JPH0446281B2 (it) 1992-07-29
AU577300B2 (en) 1988-09-22
IT8322045A0 (it) 1983-07-13
DE3483801D1 (de) 1991-02-07
JPS6038390A (ja) 1985-02-27

Similar Documents

Publication Publication Date Title
IL112585A (en) N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them
LU91498I2 (fr) Etanercept et ses dérivés pharmaceutiquement acceptables.
ATE40555T1 (de) Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.
DE3855523D1 (de) Proteine mit Faktor-VIII-Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende pharmazeutische Zusammensetzungen
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
CA1267495C (en) PURIFICATION AND ACTIVATION OF INSOLUBLE INCLUSION BODY PROTEINS
FI94960C (fi) Menetelmä ihmisen interleukiini-2:n talteensaamiseksi
AU581840B2 (en) Porphyrin derivatives
EP0267155A3 (en) Bicyclic compounds
EP0230945A3 (en) Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
EP0799827A4 (en) ACRYLAMIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
IT1163772B (it) Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
DE3485419D1 (de) Glyzerinderivate.
FR2385767A1 (fr) Gels de pullulane ioniques et procede pour leur preparation
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
AU678343B2 (en) Method and composition for determining the immunological activity of bioactive substances
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
EP1132383A4 (en) NEW AGAROFURAN DERIVATIVES, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS MEDICINE
ATE113062T1 (de) Throminbindende substanz und verfahren zu ihrer herstellung.
KR960006920A (ko) 혈액 항응고제에 대한 해독제로서 사용하기에 적합한 약제 및 이의 용도
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
SU1442548A1 (ru) Способ получени иммобилизованного протосубтилина

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730